Clinical Trials Browser

Castrate-resistant Prostate Cancer × Denosumab × Clear all

NCT01824342 2015-03-05

Denosumab for Prolonging Bone Metastasis-Free Survival in Men With Hormone-Refractory Prostate Cancer

Phase 3 Completed

18 enrolled 13 charts

Castrate-resistant Prostate Cancer